5 Safe Stocks to Buy Now According to Billionaire Dan Loeb

4. UnitedHealth Group Inc. (NYSE:UNH)

Third Point’s Stake Value: $308,532,000

Percentage of Third Point’s 13F Portfolio: 4.01%

Number of Hedge Fund Holders: 103

UnitedHealth Group Inc. (NYSE:UNH) is a diversified healthcare company operating in the US. The company offers consumer-oriented health benefit plans and services, alongside healthcare coverage and well-being services among more.

Kavin Caliendo, an analyst at UBS, raised his price target on UnitedHealth Group Inc. (NYSE:UNH) shares this July from $545 to $570. The analyst also reiterated his Neutral rating on the stock.

On July 15th, UnitedHealth Group Inc. (NYSE:UNH) raised its EPS outlook for the fiscal year of 2022 in light of its stellar second-quarter earnings results. The company had an EPS of $5.6, beating estimates by $0.4, while its revenue was $80.3 billion, also beating estimates by $652.1 million. The EPS outlook has been increased to $21.4 to $21.9, while the consensus EPS estimate for 2022 is $21.7. As UnitedHealth Group Inc. (NYSE:UNH) is a healthcare stock that not only benefits from positive analyst ratings, financial performance, and a reputation of stability in times of recession, it is among the best safe stocks in Dan Loeb’s portfolio.

Our hedge fund data for the first quarter shows 103 funds long UnitedHealth Group Inc. (NYSE:UNH), with a total stake value of $12.8 billion. In the previous quarter, 96 hedge funds were long the stock, with a total stake value of $13.7 billion.

Baron Funds, an asset management firm, mentioned UnitedHealth Group Inc. (NYSE:UNH) in its first quarter of 2022 investor letter. Here’s what they said:

UnitedHealth Group Incorporated is a leading diversified health and well- being company whose divisions include insurance arm United Healthcare and Optum, which offers care delivery and other services. Shares increased on a fourth quarter beat and a reaffirmation of what is likely conservative guidance for 2022. We believe UnitedHealth leads the health care industry in innovation and execution, as evidenced by its strong value proposition leading to Medicare Advantage share gains, strong cost controls, and its leadership position in the shift to value-based care.”